BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9050022)

  • 1. Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats.
    Kask A; Harro J; Tuomaine P; Rägo L; Männistö PT
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):267-72. PubMed ID: 9050022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: a microdialysis study in vivo.
    Hughes ZA; Stanford SC
    Psychopharmacology (Berl); 1998 Apr; 136(3):299-303. PubMed ID: 9566816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting effects of the imidazol(in)e alpha 2-adrenoceptor agonists, medetomidine, clonidine and UK 14,304 on extraneuronal levels of noradrenaline in the rat frontal cortex: evaluation using in vivo microdialysis and synaptosomal uptake studies.
    Dalley JW; Stanford SC
    Br J Pharmacol; 1995 Apr; 114(8):1717-23. PubMed ID: 7599940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence from microdialysis and synaptosomal studies of rat cortex for noradrenaline uptake sites with different sensitivities to SSRIs.
    Hughes ZA; Stanford SC
    Br J Pharmacol; 1998 Jul; 124(6):1141-8. PubMed ID: 9720784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the mechanisms that increase noradrenaline efflux after administration of d-amphetamine: a dual-probe microdialysis study in rat frontal cortex and hypothalamus.
    Géranton SM; Heal DJ; Stanford SC
    Br J Pharmacol; 2003 Aug; 139(8):1441-8. PubMed ID: 12922931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased noradrenaline efflux induced by local infusion of fluoxetine in the rat frontal cortex.
    Hughes ZA; Stanford SC
    Eur J Pharmacol; 1996 Dec; 317(1):83-90. PubMed ID: 8982723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional recovery of locus coeruleus noradrenergic neurons after DSP-4 lesion: effects on dopamine levels and neuroleptic induced-parkinsonian symptoms in rats.
    Srinivasan J; Schmidt WJ
    J Neural Transm (Vienna); 2004 Jan; 111(1):13-26. PubMed ID: 14714212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine.
    Weinshenker D; Ferrucci M; Busceti CL; Biagioni F; Lazzeri G; Liles LC; Lenzi P; Pasquali L; Murri L; Paparelli A; Fornai F
    J Neurochem; 2008 Apr; 105(2):471-83. PubMed ID: 18042179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the catecholaminergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on adrenal chromaffin cells in culture.
    Boksa P; Aitken D; Meaney M
    Biochem Pharmacol; 1989 May; 38(9):1491-8. PubMed ID: 2719722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acute and chronic electroconvulsive shock on noradrenaline release in the rat hippocampus and frontal cortex.
    Thomas DN; Nutt DJ; Holman RB
    Br J Pharmacol; 1992 Jun; 106(2):430-4. PubMed ID: 1356561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of presynaptic alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioning.
    Heal DJ; Butler SA; Prow MR; Buckett WR
    Eur J Pharmacol; 1993 Nov; 249(1):37-41. PubMed ID: 7506666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment.
    Harro J; Jossan SS; Oreland L
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):425-31. PubMed ID: 1436127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen: a microdialysis study in the rat.
    Cenci MA; Kalén P; Mandel RJ; Björklund A
    Brain Res; 1992 May; 581(2):217-28. PubMed ID: 1393530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha2-adrenoceptor modulation of cortical acetylcholine release in vivo.
    Tellez S; Colpaert F; Marien M
    Neuroscience; 1999; 89(4):1041-50. PubMed ID: 10362293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?
    Fritschy JM; Grzanna R
    Prog Brain Res; 1991; 88():257-68. PubMed ID: 1726027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atomoxetine on attention and impulsivity in the five-choice serial reaction time task in rats with lesions of dorsal noradrenergic ascending bundle.
    Liu YP; Huang TS; Tung CS; Lin CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():81-90. PubMed ID: 25151304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmitter release from transplants of fetal ventral mesencephalon or locus coeruleus in the rat frontal cortex and nucleus accumbens: effects of pharmacological and behaviorally activating stimuli.
    Cenci MA; Kalén P; Duan WM; Björklund A
    Brain Res; 1994 Apr; 641(2):225-48. PubMed ID: 8012825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons.
    Hallman H; Jonsson G
    Eur J Pharmacol; 1984 Aug; 103(3-4):269-78. PubMed ID: 6237924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of sibutramine-induced increases in extracellular noradrenaline concentration in rat frontal cortex and hypothalamus by alpha2-adrenoceptors.
    Wortley KE; Heal DJ; Stanford SC
    Br J Pharmacol; 1999 Oct; 128(3):659-66. PubMed ID: 10516646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denervation of the locus coeruleus projections by treatment with the selective neurotoxin DSP-4 [N (2-chloroethyl)-N-ethyl-2-bromobenzylamine] reduces dopamine release potential in the nucleus accumbens shell in conscious rats.
    Häidkind R; Kivastik T; Eller M; Kolts I; Oreland L; Harro J
    Neurosci Lett; 2002 Oct; 332(2):79-82. PubMed ID: 12384215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.